Partneringdesk Deals and Alliances In Musculoskeletal DiseasesInnovaro PharmalicensingJune 1, 2006 378 Pages - SKU: PL1284798 |
| Partneringdesk deals and alliances in musculoskeletal diseases provides an in-depth view of 370 deals and alliances announced in musculoskeletal diseases between 2001 and 2006, in a clear and accessible PDF format.
Reasons to purchase (USPs and key questions answered) Partneringdesk Deals and alliances in musculoskeletal diseases provides a comprehensive summary of the deals and alliances announced in the field between January 2001 and March 2006, and helps in:
Report scope The report contains:
This report provides a series of charts with analyses detailing market trends in musculoskeletal diseases deal making over the period of 2001 to 2006. Methodology This report is derived from data obtained from Pharmalicensing’s Partneringdesk deals and alliances database. The database is updated daily using industry sources. |
Additional Information
Who should buy the report This report is essential reading for board and executive management, and individuals in:
- business development
- licensing/partnering
- deal making
- business strategy
- marketing and promotion
- distribution and manufacturing (including contract services).
Aastrom Biosciences
BioXell SpA
Celltech
ChondroGene Limited
Chugai Pharmaceutical
dj Orthopedics Inc
Galapagos Genomics nv
GlaxoSmithKline
Hologic Inc
Incyte
Inion
Musculoskeletal Transplant Foundation
Novartis AG
Orthofix International NV
Orthovita
Pfizer Inc
Proskelia Pharmaceuticals
Quidel Corporation
Roche
Smith & Nephew
Stryker
Sunlight Medical Ltd
Unigene Laboratories Inc
Wyeth
Zimmer Holdings
Related Markets
Rheumatology/Arthritis Reports
- China Rheumatoid Arthritis Prescription Drug Sales Data 2006-2010
- Rheumatoid Arthritis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Market and Product Forecasts: Disease Modification in Rheumatoid Arthritis – Novel therapies plus reformulations poised to enter the market
- Rheumatoid Arthritis Market Forecast
- Market and Product Forecasts: Disease Modification in Rheumatoid Arthritis - Novel therapies plus reformulations poised to enter the market

